Skip to main content
OpenTrials
Completed

NCT Number: NCT04040933

A Study to Assess Wound Healing Efficacies of Different Adhesive Bandages

The purpose of this study is to assess the wound healing efficacy (time to complete healing) of different adhesive bandages.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

25 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Thomas J. Stephens

Richardson, Texas, 75081, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fitzpatrick Skin Type II or III
  • Uniform skin color on both volar forearms
  • Generally in good health based on medical history reported by the participant
  • -Individual has signed the Photographic Release and Informed Consent Documents along with (HIPAA) disclosure
  • Willing to have temporary (semi-permanent) dot-tattoos applied to the volar forearms

Exclusion criteria

  • Has known allergies, hypersensitivity, or adverse reactions to anesthetics, adhesive bandages, latex, wound treatment products, or any component/ingredient present in the Investigational Products (IPs)/auxiliary/ancillary products
  • Has a known history of a blood-clotting disorder, keloid formation, or a cardiovascular, hepatic, or renal disease
  • Presents with a skin condition that would, in the opinion of the PI or Study Physician, confound study results, increase risk to participant, or interfere with study evaluations
  • Has excessive hair or tattoos on either volar forearm
  • Has a known history of severe systemic immune system disorders
  • Has self-reported Type 1 or Type 2 diabetes
  • Has self-reported uncontrolled chronic diseases
  • Is taking medication that would mask an adverse event, confound study results or alter/compromise the bleeding/healing process
  • Is self-reported to be pregnant or planning to become pregnant
  • Has a body mass index (BMI) above 35
  • Is self-reported to be an alcohol or drug abuser
  • Has participated in another clinical trial within 10 days
  • Either is or lives with someone who is a current employee of any company that makes/markets adhesive bandages or first-aid products

Treatment and study plan

Marketed Adhesive Bandage #1

Device

On the randomized wound site, a marketed adhesive bandage will be applied.

Marketed Bandage #2

Device

On the randomized wound site, a marketed adhesive bandage will be applied.

Non-Marketed Bandage #1

Device

On the randomized wound site, a non-marketed adhesive bandage will be applied.

Non-Marketed Bandage #2

Device

On the randomized wound site, a non-marketed adhesive bandage will be applied.

Non-Marketed Adhesive Bandage #3

Device

On the randomized wound site, a non-marketed adhesive bandage will be applied.

Non-Marketed Adhesive Bandage #4

Device

On the randomized wound site, a non-marketed adhesive bandage will be applied.

Non-Marketed Adhesive Bandage #5

Device

On the randomized wound site, a non-marketed adhesive bandage will be applied.

Primary outcomes

  1. Time to Complete Wound Healing

    Time frame: Up to Day 16

    Time to complete wound healing: time(in days) elapsed from time of wound creation to 12 PM of day (up to Day 16) on which composite healing score(CHS) first meets complete healing criterion of being at least a score of 8 (threshold for complete healing). CHS was calculated from clinical grading of wound healing parameters as general wound appearance (0 [Poor-New or fresh wound with epithelium layer missing, wound bed appears raw and possibly oozing] to 4 [Excellent-Fully healed, skin flush against surrounding skin, slight color mismatch may be present])+smoothness (0 [Rough, uneven wound]- 4 [complete smoothness, even wound])+epithelial confluence (0 [None]- 4 [91-100%full epithelial growth]) - erythema (0 [None]- 4 [Severe]) - edema (0 [None]- 4 [Severe]) - crusting/scabbing (0 [None]- 4 [90-100% crusting/scabbing]). CHS on 25-point scale (-12 [no healing] to +12 [towards healing]) is indicative of extent of wound healing and was calculated for each wound site at each evaluation day.

Secondary outcomes

  1. Change From Baseline in Trans-Epidermal Water Loss (TEWL) Measurements

    Time frame: Day 0 (immediate after wound creation), Day 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 and 14

    Change from Baseline in TEWL was reported. TEWL is the passive transfer of water through stratum corneum and was measured for each wound site using Tewameter TM330T. TEWL is a non-invasive method to measure the integrity of stratum corneum barrier function. Tewameter probe measures the density gradient of the water evaporation from the skin indirectly by two pairs of sensors (temperature and relative humidity) inside a hollow cylinder. The probe was held in place on the skin for one measurement, for 40 sec, to ensure that a stable value has been established. The values of the last 10 sec are averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function.

  2. Change From Baseline in Clinical Grading of Wound Healing Parameter - Erythema

    Time frame: Day 0 (immediate after wound creation), Day 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 and 16

    Change from baseline in Clinical grading of wound healing parameter (erythema) was evaluated on a scale of 0 (no erythema) to 4 (severe erythema).

  3. Change From Baseline in Clinical Grading of Wound Healing Parameter - Edema

    Time frame: Day 0 (immediate after wound creation), Day 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 and 16

    Change from baseline in Clinical grading of wound healing parameter (edema) was evaluated on a scale of 0 (no edema) to 4 (severe edema).

  4. Change From Baseline in Composite Scar Score

    Time frame: Baseline and Day 28

    Change from baseline in composite scar score was reported. It was calculated as the sum of the individual parameters on the Manchester Scar Scale (Color ranges 1 [perfect] to 4 [gross mismatch]), Finish ranges 1 [matte] to 2 [shiny], Contour ranges 1 [Flush with surrounding skin] to 4 [keloid], Distortion ranges 1 [none] to 4 [severe] and Texture ranges 1 [normal] to 4 [hard]). Composite Scar Scores range from 5 to 18, with 5 representing clinically best scars and 18 representing clinically worst scars.

  5. Change From Baseline in Painful Score With Arm Resting by Side

    Time frame: Baseline, Day 1, 2, 3 and 4

    Change from baseline in painful score based on participants self-assessment questionnaire score (question 1) was reported. Participants were asked to rate each wound for pain/soreness in resting position as score from 0 (no pain) to 10 (severe pain).

  6. Change From Baseline in Painful Score With Arm in Normal Motion

    Time frame: Baseline, Day 1, 2, 3 and 4

    Change from baseline in Painful Score based on participants self-assessment questionnaire score (question 3) was reported. Participants were asked to rate each wound for pain/soreness in normal position as score from 0 (no pain) to 10 (severe pain).

  7. Change From Baseline in Itchy Score

    Time frame: Baseline, Day 1, 2, 3 and 4

    Change from baseline in itchy score based on participants self-assessment questionnaire score (question 5) was reported. Participants were asked to rate each wound for itchiness as score from 0 (no itch) to 10 (severe itch).

  8. Number of Participants With Pain Duration With Arm Resting by Side

    Time frame: Day 1, 2, 3 and 4

    Participants were asked to rate the pain as either brief, periodic, or constant in arm resting position with the Self-Assessment Questionnaire (question 2). Number of participants with pain duration (brief, periodic, or constant) with arm resting by side was reported.

  9. Number of Participants With Pain Duration With Arm in Normal Motion

    Time frame: Day 1, 2, 3 and 4

    Participants were asked to rate the pain as either brief, periodic, or constant in arm normal motion with the Self-Assessment Questionnaire (question 4). Number of participants with pain duration (brief, periodic, or constant) with arm in normal motion was reported.

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Consumer Inc. (J&JCI)

Industry

Registry information

Official study title

A 28-Day, Single-Center, Randomized, Comparator-Controlled, Proof-of-Principle Study to Assess Wound Healing Efficacies of Different Adhesive Bandages

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Aug 1, 2019
Registry last updated
Jul 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.